These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23966492)

  • 1. Evaluation of the vitek 2 AST-N269 card for detection of meropenem resistance in imipenem-susceptible meropenem-resistant Enterobacteriaceae.
    Koizumi A; Kasahara K; Komatsu Y; Ui K; Mizuno F; Nakayama A; Mikasa K
    J Clin Microbiol; 2013 Nov; 51(11):3908. PubMed ID: 23966492
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of Enterobacteriaceae isolates found to have a raised meropenem MIC by Vitek 2.
    Hunt AC; Gibb AP
    J Antimicrob Chemother; 2012 Apr; 67(4):1045-6. PubMed ID: 22258920
    [No Abstract]   [Full Text] [Related]  

  • 3. Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems.
    Harino T; Kayama S; Kuwahara R; Kashiyama S; Shigemoto N; Onodera M; Yokozaki M; Ohge H; Sugai M
    J Clin Microbiol; 2013 Aug; 51(8):2735-8. PubMed ID: 23720796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae?
    Pasteran F; Lucero C; Soloaga R; Rapoport M; Corso A
    J Clin Microbiol; 2011 Feb; 49(2):697-701. PubMed ID: 21159944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Meropenem Concentration on the Detection of Low Numbers of Carbapenem-Resistant Enterobacteriaceae.
    Tanner WD; Atkinson RM; Goel RK; Porucznik CA; Benson LS; VanDerslice JA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):712-3. PubMed ID: 26552977
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of Imipenem-Susceptible but Meropenem-Resistant
    Kanazawa S; Sato T; Kohira N; Ito-Horiyama T; Tsuji M; Yamano Y
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438934
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.
    Piddock LJ; Turner HL
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1186-91. PubMed ID: 1291320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins.
    MacGowan AP; Bowker KE; Bedford KA; Holt HA; Reeves DS; Hedges A
    J Antimicrob Chemother; 1995 Feb; 35(2):333-7. PubMed ID: 7759397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterization of Imipenem-Resistant, Meropenem-Susceptible Pseudomonas aeruginosa with blaVIM₋₂ Phenotype: Potential for Dissemination.
    Pragasam AK; Raghanivedha M; Anandan S; Veeraraghavan B
    Jpn J Infect Dis; 2016; 69(2):159-60. PubMed ID: 26567829
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
    Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
    J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro efficacy of ertapenem, imipenem and meropenem in the infections caused by the Enterobacteriaceae strains family.
    Guzek A; Tomaszewski D; Rybicki Z; Truszczyński A; Barański M; Korzeniewski K
    Anaesthesiol Intensive Ther; 2013; 45(2):67-72. PubMed ID: 23877897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.
    Tenover FC; Kalsi RK; Williams PP; Carey RB; Stocker S; Lonsway D; Rasheed JK; Biddle JW; McGowan JE; Hanna B
    Emerg Infect Dis; 2006 Aug; 12(8):1209-13. PubMed ID: 16965699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
    Walsh F; Bracher S; Turner P; Amyes S
    Chemotherapy; 2007; 53(6):407-9. PubMed ID: 17934261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
    Hartl R; Widhalm S; Kerschner H; Apfalter P
    Clin Microbiol Infect; 2013 May; 19(5):E230-2. PubMed ID: 23397897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of meropenem and four other antibiotics against 554 clinical strains obtained from Beijing in 1999.
    Wang H; Chen M; Xie X; Xu Y; Zhang X; Zhang Y; Yuan Y; Wang C; Liu J; Wang P
    J Infect Chemother; 2000 Sep; 6(3):178-83. PubMed ID: 11810561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the in vitro postantibiotic effect of meropenem and imipenem versus selected enterobacteriaceae and other pathogens.
    Nadler HL; Sheikh W
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):71-3. PubMed ID: 8359011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.
    Tsakris A; Themeli-Digalaki K; Poulou A; Vrioni G; Voulgari E; Koumaki V; Agodi A; Pournaras S; Sofianou D
    J Clin Microbiol; 2011 Aug; 49(8):2804-9. PubMed ID: 21632901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
    Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
    J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.